GRHL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.485200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.738800E-01
Normal-vs-Stage2
3.529800E-01
Normal-vs-Stage3
7.881600E-01
Normal-vs-Stage4
5.442600E-01
Stage1-vs-Stage2
8.466200E-01
Stage1-vs-Stage3
3.333800E-01
Stage1-vs-Stage4
9.002000E-01
Stage2-vs-Stage3
1.570970E-01
Stage2-vs-Stage4
9.772800E-01
Stage3-vs-Stage4
3.009800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.626800E-01
Normal-vs-AfricanAmerican
4.904600E-01
Normal-vs-Asian
3.713800E-01
Caucasian-vs-AfricanAmerican
6.201000E-01
Caucasian-vs-Asian
4.005600E-01
AfricanAmerican-vs-Asian
8.807800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.929800E-01
Normal-vs-Female
5.435600E-01
Male-vs-Female
2.245800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.548200E-01
Normal-vs-Age(41-60Yrs)
3.707000E-01
Normal-vs-Age(61-80Yrs)
5.228800E-01
Normal-vs-Age(81-100Yrs)
3.833600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.107400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.621600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.442000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.321500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.360800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.644800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.473200E-01
Normal-vs-Daily Drinker
5.393600E-01
Normal-vs-Weekly Drinker
8.831000E-01
Normal-vs-Occasional Drinker
2.933000E-01
Normal-vs-Social Drinker
5.290800E-01
Non Drinker-vs-Daily Drinker
7.651800E-01
Non Drinker-vs-Weekly Drinker
1.470790E-01
Non Drinker-vs-Occasional Drinker
3.785200E-01
Non Drinker-vs-Social Drinker
8.204000E-01
Daily Drinker-vs-Weekly Drinker
3.473000E-01
Daily Drinker-vs-Occasional Drinker
3.425600E-01
Daily Drinker-vs-Social Drinker
9.688000E-01
Weekly Drinker-vs-Occasional Drinker
7.795700E-02
Weekly Drinker-vs-Social Drinker
3.513000E-01
Occasional Drinker-vs-Social Drinker
4.058000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.682360E-01
Normal-vs-Grade 2
2.688400E-02
Normal-vs-Grade 3
2.300400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.153200E-01
Grade 1-vs-Grade 3
7.744400E-03
Grade 1-vs-Grade 4
1.682360E-01
Grade 2-vs-Grade 3
7.461500E-03
Grade 2-vs-Grade 4
2.688400E-02
Grade 3-vs-Grade 4
2.300400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.623400E-01
Normal-vs-NonDiabetic
4.474000E-01
Diabetic-vs-NonDiabetic
5.331800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.614360E-01
Normal-vs-NoPancreatitis
5.154000E-01
Pancreatitis-vs-NoPancreatitis
6.942200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.980800E-01
Normal-vs-N1
3.641200E-01
N0-vs-N1
1.666850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.906500E-02
Normal-vs-TP53-NonMutant
5.444000E-01
TP53-Mutant-vs-TP53-NonMutant
5.53559999999509E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
